Last Price
11.75
Today's Change
+1.46 (14.18%)
Day's Change
11.20 - 12.37
Trading Volume
740,687
Profile
AURA
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Elisabet de los Pinos Ph.D. Dr. Elisabet de los Pinos Ph.D.
Full Time Employees: 88 88
IPO Date: 2021-10-29 2021-10-29
CIK: 0001501796 0001501796
ISIN: US05153U1079 US05153U1079
CUSIP: 05153U107 05153U107
Beta: 0.37 0.37
Last Dividend: 0.00 0.00
Dcf Diff: 9.75 9.75
Dcf: 0.54 0.54
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Cheaper Energy Products Depress US Import Prices in September
2
CEO Morning Brief
Cathay Asks Boeing to Remain Transparent About Aircraft Delays
3
CEO Morning Brief
Trump Defends Tariff Plan While Pressing for More Fed Influence
4
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
